Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strauss, B. L.
Right arrow Articles by Tejada, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strauss, B. L.
Right arrow Articles by Tejada, F.

Chest, Vol 71, 607-611, Copyright © 1977 by American College of Chest Physicians

ARTICLES

Cardiac metastases in lung cancer

BL Strauss, MJ Matthews, MH Cohen, R Simon and F Tejada

Cardiac metastases from bronchogenic carcinoma are not commonly diagnosed prior to death. This study isolates factors associated wtih the development of cardiac involvement. Four hundred eighteen consecutive patients with lung cancer who had autopsies were studied. Twenty-five percent of these patients had cardiac involvement. Factors associated with cardiac metastases were (1) histologic cell type of the tumor, (2) aggressive therapy, (3) extent of disease, and (4) tumor differentiation. The presence of cardiac metatases was not related to the length of survival. Clinical signs of cardiac involvement included an enlarging heart on the chest x-ray film, development of congestive heart failure, or electrocardiographic changes. Suspicion of cardiac metastases in high-risk individuals, prompt diagnostic evaluation, and rapid institution of therapy may improve the outlook for many patients, since reaccumulation of fluid was generally slow.


This article has been cited by other articles:


Home page
 JCOHome page
M.-S. Tsai, P. C.-I. Ko, J.-Y. Shih, Y.-L. Chang, S.-C. Chen, W.-C. Chiang, and W.-J. Chen
Cardiac Involvement in Malignancies: CASE 1. Favorable Outcome of a Patient With Cardiac Invasion From Non-Small-Cell Lung Carcinoma
J. Clin. Oncol., July 1, 2004; 22(13): 2740 - 2742.
[Full Text] [PDF]

Home page
 ThoraxHome page
J M Maskill, A Rother, and S Seevanayagam
Transoesophageal echocardiography and lung cancer staging
Thorax, August 1, 2003; 58(8): 735 - 735.
[Full Text] [PDF]

Home page
 ChestHome page
P.-C. Wang, K.-Y. Yang, J.-Y. Chao, J. M. Liu, R.-P. Perng, and S.-H. Yen
Prognostic Role of Pericardial Fluid Cytology in Cardiac Tamponade Associated With Non-small Cell Lung Cancer
Chest, September 1, 2000; 118(3): 744 - 749.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1977 by the American College of Chest Physicians.